The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Hyperprogression in cancer patients on immunotherapeutic agents.

Sumi  Dey

No Relationships to Disclose

Midhhath Afza  Munavar Ali

No Relationships to Disclose

Valerie  Gunchick

No Relationships to Disclose

Joshua  Bugbee

No Relationships to Disclose

Vaibhav  Sahai

Consulting or Advisory Role - AstraZeneca; Celgene; Halozyme; Incyte; Ipsen; Klus Pharma; Newlink Genetics; QED Therapeutics

Research Funding - Agios (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); FibroGen (Inst); Halozyme (Inst); Incyte (Inst); Ipsen (Inst); MedImmune (Inst); Rafael Pharmaceuticals (Inst)

Travel, Accommodations, Expenses - ASCO; FibroGen; FibroGen